Organon & Co.
(NYSE) OGN
Organon & Co. Financials at a Glance
Market Cap
$3.56B
Revenue (TTM)
$6.16B
Net Income (TTM)
$246.00M
EPS (TTM)
$0.94
P/E Ratio
14.44
Dividend
$0.08
Beta (Volatility)
0.80 (Low)
Dividend
$0.08
Beta (Volatility)
0.80 (Low)
Price
$13.57
Volume
53,463
Open
$13.56
Price
$13.57
Volume
53,463
Open
$13.56
Previous Close
$13.57
Daily Range
$13.53 - $13.58
52-Week Range
$5.69 - $13.60
Estimated Earnings Date
Aug 4, 2026
Dividend
$0.08
Beta (Volatility)
0.80 (Low)
Price
$13.57
Volume
53,463
Open
$13.56
Previous Close
$13.57
Daily Range
$13.53 - $13.58
52-Week Range
$5.69 - $13.60
Estimated Earnings Date
Aug 4, 2026
OGN News
OGN: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Organon & Co.
Industry
Pharmaceuticals
Sector
Health CareEmployees
10,000
CEO
Joseph T. Morrissey, Jr., MBA
Website
www.organon.comHeadquarters
Jersey City, NJ 07302, US
OGN Financials
Key Financial Metrics (TTM)
Gross Margin
53.11%
Operating Margin
19.23%
Net Income Margin
3.99%
Return on Equity
29.87%
Return on Capital
13.45%
Return on Assets
1.89%
Earnings Yield
6.93%
Dividend Yield
0.59%
Payout Ratio
8.94%
Stock Overview
Market Cap
$3.56B
Shares Outstanding
262.61M
Volume
53.46K
Avg. Volume
8.41M
Financials (TTM)
Gross Profit
$3.27B
Operating Income
$1.19B
EBITDA
$1.38B
Operating Cash Flow
$850.00M
Capital Expenditure
-$236.00M
Free Cash Flow
$614.00M
Cash & ST Invst.
$1.12B
Total Debt
$8.57B
Organon & Co. Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.46B
-3.5%
Gross Profit
$783.00M
-6.9%
Gross Margin
53.63%
N/A
Market Cap
$3.56B
N/A
Market Cap/Employee
$355.84K
N/A
Employees
10,000
N/A
Net Income
$146.00M
+67.8%
EBITDA
$409.00M
+25.8%
Quarterly Fundamentals
Total Cash
$1.12B
+104.0%
Total Debt
$8.57B
-4.3%
Accounts Receivable
$1.39B
-5.6%
Inventory
$1.37B
+0.8%
Long Term Debt
$8.55B
-4.3%
Short Term Debt
$16.00M
-20.0%
Return on Assets
1.89%
N/A
Return on Invested Capital
11.29%
N/A
Free Cash Flow
$188.00M
+954.5%
Operating Cash Flow
$225.00M
+200.0%